Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder

George I. Papakostas, Timothy J. Petersen, Dan V. Iosifescu, Paul Summergrad, Katherine G. Sklarsky, Jonathan E. Alpert, Andrew A. Nierenberg, Maurizio Fava

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: In the present study we assessed the relationship between somatic symptoms and the time to onset of clinical response to fluoxetine in patients with major depressive disorder (MDD). Method: 87 outpatients (mean age = 41.4 ± 10.2 years; 59.8% women) with DSM-III-R MDD who had sustained acute response to fluoxetine completed the Symptom Questionnaire (SQ) at baseline. Onset of response was defined as a 30% decrease in the total score for the 17-item Hamilton Rating Scale for Depression that led to a 50% decrease by week 8. With the use of 2 separate multiple regressions, controlling for the severity of depression at baseline, we then assessed the relationship between the number of somatic symptoms as assessed by the SQ subscale for somatic symptoms (SQ-SS) and both the time to onset of clinical response and the time to clinical response. The study was conducted between November 1992 and January 1999. Results: A greater number of somatic symptoms at baseline predicted a greater amount of time to onset of clinical response to fluoxetine (p = .0233). The relationship between SQ-SS scores and time to response was not found to be statistically significant (p > .05). Conclusion: Somatic symptoms of depression were found to be associated with a delayed onset of antidepressant response to fluoxetine in MDD.

Original languageEnglish (US)
Pages (from-to)543-546
Number of pages4
JournalJournal of Clinical Psychiatry
Volume65
Issue number4
DOIs
StatePublished - Apr 2004
Externally publishedYes

Fingerprint

Fluoxetine
Major Depressive Disorder
Depression
Diagnostic and Statistical Manual of Mental Disorders
Antidepressive Agents
Reaction Time
Outpatients
Medically Unexplained Symptoms
Surveys and Questionnaires

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Papakostas, G. I., Petersen, T. J., Iosifescu, D. V., Summergrad, P., Sklarsky, K. G., Alpert, J. E., ... Fava, M. (2004). Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. Journal of Clinical Psychiatry, 65(4), 543-546. https://doi.org/10.4088/JCP.v65n0414

Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. / Papakostas, George I.; Petersen, Timothy J.; Iosifescu, Dan V.; Summergrad, Paul; Sklarsky, Katherine G.; Alpert, Jonathan E.; Nierenberg, Andrew A.; Fava, Maurizio.

In: Journal of Clinical Psychiatry, Vol. 65, No. 4, 04.2004, p. 543-546.

Research output: Contribution to journalArticle

Papakostas, GI, Petersen, TJ, Iosifescu, DV, Summergrad, P, Sklarsky, KG, Alpert, JE, Nierenberg, AA & Fava, M 2004, 'Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder', Journal of Clinical Psychiatry, vol. 65, no. 4, pp. 543-546. https://doi.org/10.4088/JCP.v65n0414
Papakostas, George I. ; Petersen, Timothy J. ; Iosifescu, Dan V. ; Summergrad, Paul ; Sklarsky, Katherine G. ; Alpert, Jonathan E. ; Nierenberg, Andrew A. ; Fava, Maurizio. / Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. In: Journal of Clinical Psychiatry. 2004 ; Vol. 65, No. 4. pp. 543-546.
@article{67d5a7e938f14a7c9479220f9ec692a4,
title = "Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder",
abstract = "Objective: In the present study we assessed the relationship between somatic symptoms and the time to onset of clinical response to fluoxetine in patients with major depressive disorder (MDD). Method: 87 outpatients (mean age = 41.4 ± 10.2 years; 59.8{\%} women) with DSM-III-R MDD who had sustained acute response to fluoxetine completed the Symptom Questionnaire (SQ) at baseline. Onset of response was defined as a 30{\%} decrease in the total score for the 17-item Hamilton Rating Scale for Depression that led to a 50{\%} decrease by week 8. With the use of 2 separate multiple regressions, controlling for the severity of depression at baseline, we then assessed the relationship between the number of somatic symptoms as assessed by the SQ subscale for somatic symptoms (SQ-SS) and both the time to onset of clinical response and the time to clinical response. The study was conducted between November 1992 and January 1999. Results: A greater number of somatic symptoms at baseline predicted a greater amount of time to onset of clinical response to fluoxetine (p = .0233). The relationship between SQ-SS scores and time to response was not found to be statistically significant (p > .05). Conclusion: Somatic symptoms of depression were found to be associated with a delayed onset of antidepressant response to fluoxetine in MDD.",
author = "Papakostas, {George I.} and Petersen, {Timothy J.} and Iosifescu, {Dan V.} and Paul Summergrad and Sklarsky, {Katherine G.} and Alpert, {Jonathan E.} and Nierenberg, {Andrew A.} and Maurizio Fava",
year = "2004",
month = "4",
doi = "10.4088/JCP.v65n0414",
language = "English (US)",
volume = "65",
pages = "543--546",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "4",

}

TY - JOUR

T1 - Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder

AU - Papakostas, George I.

AU - Petersen, Timothy J.

AU - Iosifescu, Dan V.

AU - Summergrad, Paul

AU - Sklarsky, Katherine G.

AU - Alpert, Jonathan E.

AU - Nierenberg, Andrew A.

AU - Fava, Maurizio

PY - 2004/4

Y1 - 2004/4

N2 - Objective: In the present study we assessed the relationship between somatic symptoms and the time to onset of clinical response to fluoxetine in patients with major depressive disorder (MDD). Method: 87 outpatients (mean age = 41.4 ± 10.2 years; 59.8% women) with DSM-III-R MDD who had sustained acute response to fluoxetine completed the Symptom Questionnaire (SQ) at baseline. Onset of response was defined as a 30% decrease in the total score for the 17-item Hamilton Rating Scale for Depression that led to a 50% decrease by week 8. With the use of 2 separate multiple regressions, controlling for the severity of depression at baseline, we then assessed the relationship between the number of somatic symptoms as assessed by the SQ subscale for somatic symptoms (SQ-SS) and both the time to onset of clinical response and the time to clinical response. The study was conducted between November 1992 and January 1999. Results: A greater number of somatic symptoms at baseline predicted a greater amount of time to onset of clinical response to fluoxetine (p = .0233). The relationship between SQ-SS scores and time to response was not found to be statistically significant (p > .05). Conclusion: Somatic symptoms of depression were found to be associated with a delayed onset of antidepressant response to fluoxetine in MDD.

AB - Objective: In the present study we assessed the relationship between somatic symptoms and the time to onset of clinical response to fluoxetine in patients with major depressive disorder (MDD). Method: 87 outpatients (mean age = 41.4 ± 10.2 years; 59.8% women) with DSM-III-R MDD who had sustained acute response to fluoxetine completed the Symptom Questionnaire (SQ) at baseline. Onset of response was defined as a 30% decrease in the total score for the 17-item Hamilton Rating Scale for Depression that led to a 50% decrease by week 8. With the use of 2 separate multiple regressions, controlling for the severity of depression at baseline, we then assessed the relationship between the number of somatic symptoms as assessed by the SQ subscale for somatic symptoms (SQ-SS) and both the time to onset of clinical response and the time to clinical response. The study was conducted between November 1992 and January 1999. Results: A greater number of somatic symptoms at baseline predicted a greater amount of time to onset of clinical response to fluoxetine (p = .0233). The relationship between SQ-SS scores and time to response was not found to be statistically significant (p > .05). Conclusion: Somatic symptoms of depression were found to be associated with a delayed onset of antidepressant response to fluoxetine in MDD.

UR - http://www.scopus.com/inward/record.url?scp=2442482557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442482557&partnerID=8YFLogxK

U2 - 10.4088/JCP.v65n0414

DO - 10.4088/JCP.v65n0414

M3 - Article

C2 - 15119918

AN - SCOPUS:2442482557

VL - 65

SP - 543

EP - 546

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 4

ER -